Resilience in a Bear Market: Johnson & Johnson's Growth Strategies

This chapter examines Johnson & Johnson's financial performance in a tough healthcare landscape, focusing on its successful medical device division and oncology portfolio. Despite challenges like patent expirations and legal issues, the company's drug business shows robust growth from both new and established therapies.